Clinical Trial: A Study to Assess the Adverse Events and How Oral ABBV-1606 Moves Through the Body of Healthy Adult Participants.

U.S., Nov. 14 -- ClinicalTrials.gov registry received information related to the study (NCT07935564) titled 'A Study to Assess the Adverse Events and How Oral ABBV-1606 Moves Through the Body of Healthy Adult Participants.' on Sept. 18, 2025.

Brief Summary: This study will assess the adverse events, tolerability, and how oral ascending doses of ABBV-1606 moves through the body of healthy adult participants.

Study Start Date: Nov. 10

Study Type: INTERVENTIONAL

Condition: Healthy Volunteer

Intervention: DRUG: ABBV-1606

Oral Solution

DRUG: Placebo

Oral Solution

Recruitment Status: NOT_YET_RECRUITING

Sponsor: AbbVie

Disclaimer: Curated by HT Syndication....